Bionovo to present phase 1B trial results of BZL101 in metastatic breast cancer

[News]

Bionovo, Inc. has announced the company will present results from the Phase 1B clinical trial of their lead drug candidate for advanced metastatic breast cancer, BZL101, at the Society for Integrative Oncology's Fifth International Conference in Atlanta, Georgia.

More... (http://www.news-medical.net/?id=43234)